Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diversity of Mechanisms Underlying Latent TGF-β Activation in Recessive Dystrophic Epidermolysis Bullosa
Eijiro Akasaka, Svenja Kleiser, Gerhard Sengle, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 6, pp. 1450-1460.e9
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Fibrosis: cross-organ biology and pathways to development of innovative drugs
Florian Rieder, Laura E. Nagy, Toby M. Maher, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
Resveratrol-laden mesoporous silica nanoparticles regulate the autophagy and apoptosis via ROS-mediated p38-MAPK/HIF-1a /p53 signaling in hypertrophic scar fibroblasts
Jun Zuo, Shaolin Ma
Heliyon (2024) Vol. 10, Iss. 4, pp. e24985-e24985
Open Access | Times Cited: 6
Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa
Grace Tartaglia, Qingqing Cao, Zachary M. Padron, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5104-5104
Open Access | Times Cited: 34
Dystrophic Epidermolysis Bullosa: Secondary Disease Mechanisms and Disease Modifiers
Alexander Nyström, Leena Bruckner‐Tuderman, Dimitra Kiritsi
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 33
Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa
Andrew P. South, Martin Laimer, Mouhamed Gueye, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 11, pp. 2108-2119
Open Access | Times Cited: 14
Dipeptidyl Peptidase-4–Mediated Fibronectin Processing Evokes a Profibrotic Extracellular Matrix
Karina A. Zeyer, Olivier Bornert, Valentin Nelea, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 11, pp. 2477-2487.e13
Open Access | Times Cited: 5
Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa
Catherine Santucci, Madalina Alexandru, Xinyi Chen, et al.
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110805-110805
Open Access | Times Cited: 4
Repurposing diacerein for the treatment of chronic wounds in recessive‐dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase‐9 expression
Sonja Dorfer, Michael Ablinger, Monika Wimmer, et al.
The Journal of Dermatology (2025)
Open Access
The role of fibroblasts in dystrophic epidermolysis bullosa pathogenesis and current treatment approaches
Alexander Nyström, Céline Pattaroni, Johannes S. Kern
JID Innovations (2025) Vol. 5, Iss. 3, pp. 100353-100353
Open Access
Dystrophic Epidermolysis Bullosa - from biochemistry to interventions
Alexander Nyström
Matrix Biology (2025)
Open Access
Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA
Serap Elçin-Guinot, Simon Lagies, Yoav Avi-Guy, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2272-2272
Open Access
Collagen VII maintains proteostasis in dermal fibroblasts by scaffolding TANGO1 cargo
Qingqing Cao, Grace Tartaglia, Michael J. Alexander, et al.
Matrix Biology (2022) Vol. 111, pp. 226-244
Open Access | Times Cited: 14
Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis Bullosa
Christine Gretzmeier, Didier Pin, Johannes S. Kern, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 4, pp. 1094-1102.e3
Open Access | Times Cited: 16
Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis
Esteban Chacón-Solano, Carlos León, Marta Carretero, et al.
Matrix Biology (2022) Vol. 111, pp. 189-206
Open Access | Times Cited: 12
Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial
Dimitra Kiritsi, Franziska Schauer, Stella Gewert, et al.
EClinicalMedicine (2024) Vol. 77, pp. 102900-102900
Open Access | Times Cited: 2
Porous Se@SiO2 Nanoparticles Enhance Wound Healing by ROS-PI3K/Akt Pathway in Dermal Fibroblasts and Reduce Scar Formation
Bo-Yu Yang, Zhiyuan Zhou, Shiyun Liu, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 11
Epidermal or Dermal Collagen VII Is Sufficient for Skin Integrity: Insights to Anchoring Fibril Homeostasis
Gregor Conradt, Ingrid Haußer, Alexander Nyström
Journal of Investigative Dermatology (2023) Vol. 144, Iss. 6, pp. 1301-1310.e7
Closed Access | Times Cited: 6
Bioengineered Efficacy Models of Skin Disease: Advances in the Last 10 Years
Diana Nicole Stanton, Gitali Ganguli‐Indra, Arup K. Indra, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 319-319
Open Access | Times Cited: 8
Maintenance of chronicity signatures in fibroblasts isolated from recessive dystrophic epidermolysis bullosa chronic wound dressings under culture conditions
Cristian De Gregorio, Evelyng Catalán, Gabriel Garrido, et al.
Biological Research (2023) Vol. 56, Iss. 1
Open Access | Times Cited: 4
hTERT-Driven Immortalization of RDEB Fibroblast and Keratinocyte Cell Lines Followed by Cre-Mediated Transgene Elimination
Н. А. Евтушенко, Arkadii K. Beilin, Э. Б. Дашинимаев, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3809-3809
Open Access | Times Cited: 10
Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa
Grace Tartaglia, Ignacia Fuentes, Neil Patel, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 870-884
Open Access | Times Cited: 1
Alterations in the microenvironment of junctional epidermolysis bullosa keratinocytes: a gene expression study
Yao Wang, Maria Elena Hess, Yan Tan, et al.
Matrix Biology (2024)
Closed Access | Times Cited: 1
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas
Julia Illmer, Roland Zauner, Josefina Piñón Hofbauer, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 1, pp. 80-93
Open Access | Times Cited: 3
The decreased expression of integrin αv is involved in T-2 toxin-induced extracellular matrix degradation in chondrocytes
Hui Wang, Meng Zhang, Ying Zhang, et al.
Toxicon (2021) Vol. 199, pp. 109-116
Closed Access | Times Cited: 6
Fibrosis as a Risk Factor for Cutaneous Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa: A Systematic Review
Brenda Lamônica Rodrigues de Azevedo, Gabriel Marim Roni, Rosalie Matuk Fuentes Torrelio, et al.
Journal of Pediatric Genetics (2023) Vol. 12, Iss. 02, pp. 097-104
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top